Reported results
- Revenue in the third quarter of 2026 was $9.4 million as compared to $11.8 million in the third quarter of 2025.
- Net loss for the third quarter of 2026 was $55.7 million, or $1.63 basic and diluted net loss per share, as compared to a net loss of $35.5 million, or $1.87 basic and diluted loss per share, in the third quarter of 2025.
- Research and development (R&D) expense in the third quarter of 2026 was $44.1 million as compared to $27.3 million for the third quarter of 2025.
- General and administrative (G&A) expense was $24.6 million in the third quarter of 2026 as compared to $16.1 million in the third quarter of 2025.
- Cash and investments in marketable securities on September 30, 2026, were $952.9 million as compared to $245.8 million on December 31, 2025.
Price and volatility reaction
The stock moved +0.1% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 37.25 | 2026-11-12 |
| Close after release | 37.27 | 2026-11-13 |
| Realised move | +0.1% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.
